6th Annual Diabetes Conference to feature ocular drug delivery in diabetic retinopathy pSivida Corp.

6th Annual Diabetes Conference to feature ocular drug delivery in diabetic retinopathy pSivida Corp. , a innovator in the development of small, sustained-release drug delivery technology, with two of the just three ophthalmic sustained-launch delivery products authorized by the FDA for treatment of back of the optical eyes diseases, announced that its ceo, Dr. Paul Ashton, will discuss ocular medication delivery in diabetic retinopathy throughout a presentation at the 6th Annual Diabetes Meeting in London, friday on, January 22. Related StoriesStudy explores diabetes screening for patients with severe mental illnessStudy suggests need for specific treatment options for adolescents with starting point type 2 diabetesStudy discovers high prevalence of dehydration in the elderly living in UK care homes In his display Dr.The saying that what gets measured, gets done, holds true in healthcare. Even high-performing hospitals can move the rate of certain complications toward zero by focusing on their results, measuring in the right way, and targeting poorer outcomes and emerging problem areas. 3. High-quality data is essential for quality improvement. Today have a range of tools Hospitals, including ACS registries and proprietary dashboards, to create quality targets, measure performance, and tackle regions of concern. 4. Quality thrives in a supportive culture. Team work and a tradition where every member of a healthcare facility staff feels a sense of responsibility for patient safety and quality care are essential to sustained quality improvement.